Literature DB >> 25210538

New trends in androgen deprivation therapy: Summary of key research presented at AUA 2014.

.   

Abstract

At the 2014 Annual Meeting of the American Urological Association (AUA), there were a number of educational sessions presenting new research regarding the use of androgen deprivation therapy (ADT). Two important themes related to ADT that emerged during the conference were the relationship between ADT and cardiovascular (CV) risk and the optimization of testosterone suppression. The following sections will provide highlights from the AUA sessions on these 2 topics.

Entities:  

Year:  2014        PMID: 25210538      PMCID: PMC4145690          DOI: 10.5489/cuaj.2284

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  2 in total

1.  Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist.

Authors:  Peter C Albertsen; Laurence Klotz; Bertrand Tombal; James Grady; Tine K Olesen; Jan Nilsson
Journal:  Eur Urol       Date:  2013-11-01       Impact factor: 20.096

2.  An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer.

Authors:  Ferenc G Rick; Norman L Block; Andrew V Schally
Journal:  Onco Targets Ther       Date:  2013-04-16       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.